Pinnacle Wealth Management Advisory Group LLC Trims Stake in Definitive Healthcare Corp. $DH

Pinnacle Wealth Management Advisory Group LLC lessened its position in Definitive Healthcare Corp. (NASDAQ:DH) by 50.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 130,000 shares of the company’s stock after selling 130,000 shares during the quarter. Pinnacle Wealth Management Advisory Group LLC’s holdings in Definitive Healthcare were worth $507,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also bought and sold shares of the business. Farther Finance Advisors LLC bought a new stake in Definitive Healthcare in the second quarter worth $33,000. Invesco Ltd. raised its holdings in Definitive Healthcare by 19.3% in the first quarter. Invesco Ltd. now owns 61,871 shares of the company’s stock worth $179,000 after buying an additional 10,012 shares during the last quarter. Savant Capital LLC bought a new position in shares of Definitive Healthcare in the second quarter worth approximately $45,000. Los Angeles Capital Management LLC purchased a new stake in shares of Definitive Healthcare during the second quarter valued at approximately $51,000. Finally, CWM LLC increased its position in shares of Definitive Healthcare by 212.4% during the second quarter. CWM LLC now owns 24,498 shares of the company’s stock valued at $96,000 after acquiring an additional 16,657 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Up 10.6%

DH stock opened at $2.93 on Monday. The business’s 50-day moving average price is $3.46 and its 200-day moving average price is $3.58. The stock has a market cap of $419.40 million, a P/E ratio of -1.75 and a beta of 1.61. Definitive Healthcare Corp. has a twelve month low of $2.15 and a twelve month high of $5.68. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.39.

Definitive Healthcare (NASDAQ:DH) last released its earnings results on Thursday, November 6th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.01. Definitive Healthcare had a negative net margin of 77.88% and a positive return on equity of 3.14%. The company had revenue of $60.05 million for the quarter, compared to analysts’ expectations of $59.51 million. Definitive Healthcare has set its FY 2025 guidance at 0.230-0.240 EPS. Q4 2025 guidance at 0.050-0.060 EPS. On average, equities research analysts forecast that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on DH. Robert W. Baird set a $4.00 price objective on Definitive Healthcare in a research report on Friday, August 8th. William Blair raised Definitive Healthcare to a “strong-buy” rating in a report on Thursday. Stifel Nicolaus increased their price objective on Definitive Healthcare from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Definitive Healthcare in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $4.28.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.